Pages that link to "Q50889035"

The following pages link to The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial. (Q50889035):

Displaying 28 items.

• Interventions to improve the appropriate use of polypharmacy for older people (Q24193171) (← links)
• Implementation of treatment guidelines for specialist mental health care (Q24201102) (← links)
• Computer-generated reminders delivered on paper to healthcare professionals; effects on professional practice and health care outcomes (Q24202200) (← links)
• A systematic review of educational interventions to change behaviour of prescribers in hospital settings, with a particular emphasis on new prescribers (Q26824417) (← links)
• National Trends in Child and Adolescent Psychotropic Polypharmacy in Office-Based Practice, 1996-2007 (Q34187891) (← links)
• Antipsychotic polypharmacy in a regional health service: a population-based study. (Q34269517) (← links)
• Factors associated with non evidence-based prescribing of antipsychotics (Q34642808) (← links)
• Reducing the rates of prescribing high-dose antipsychotics and polypharmacy on psychiatric inpatient and intensive care units: results of a 6-year quality improvement programme (Q35044176) (← links)
• Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose method. (Q35224262) (← links)
• Polypharmacy in psychiatry: a review (Q36841579) (← links)
• Antipsychotic Medication Prescribing Practices Among Adult Patients Discharged From State Psychiatric Inpatient Hospitals (Q37116547) (← links)
• Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales (Q37216848) (← links)
• Antipsychotic polypharmacy in schizophrenia: benefits and risks (Q37863093) (← links)
• Improving prescribing practice in psychiatry: the experience of the Prescribing Observatory for Mental Health (POMH-UK). (Q37949397) (← links)
• Critical review of antipsychotic polypharmacy in the treatment of schizophrenia (Q38020263) (← links)
• History, background, concepts and current use of comedication and polypharmacy in psychiatry. (Q38138638) (← links)
• Polypharmacy and bipolar disorder: what's personality got to do with it? (Q38143335) (← links)
• A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health (Q38168741) (← links)
• Implementation of treatment guidelines for specialist mental health care (Q39039245) (← links)
• Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia (Q46971915) (← links)
• Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy. (Q48321579) (← links)
• Low doses of antipsychotic drugs for hospitalized schizophrenia patients in East Asia: 2004 vs. 2001. (Q51887355) (← links)
• Schizophrenia (Q55868331) (← links)
• Interventions to improve the appropriate use of polypharmacy for older people (Q57688822) (← links)
• Review of structured guides for deprescribing. (Q64976468) (← links)
• Psychotropic drug prescribing in a Nigerian psychiatric hospital (Q90052048) (← links)
• Effect of Peer Comparison Letters for High-Volume Primary Care Prescribers of Quetiapine in Older and Disabled Adults: A Randomized Clinical Trial (Q90728055) (← links)
• The Prevalence and Factors Associated With Antipsychotic Polypharmacy in a Forensic Psychiatric Sample (Q96303291) (← links)